Bevacizumab First Matches Aflibercept for Diabetic Macular Edema

Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy.
Medscape Medical News

Full Story →